PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
13-Jun-2024 DC Healthcare's Approve All Resolutions in AGM DC Healthcare
12-Jun-2024 Scottish Medicines Consortium (SMC) Approves First Subcutaneous Bispecific Treatment Option Tepkinly®▼(epcoritamab) for Adults with an Aggressive Form of Blood Cancer After Two or More Lines of Systemic Therapy AbbVie
12-Jun-2024 BellaSeno Reports Positive Interim Findings of Australian Clinical Trials in Breast Scaffold Patients BellaSeno GmbH
11-Jun-2024 Bespak reaches key milestone in the expansion of its manufacturing capacity, with further expansion plans underway to meet global customer demand for climate friendly inhalers Bespak
11-Jun-2024 Santhera Announces Launch of Early Access Program in China for AGAMREE by its Partner Sperogenix Santhera
11-Jun-2024 Commit Biologics to present data on its Bispecific Complement Engaging (BiCE™) platform at the 16th International Conference on Complement Therapeutics Commit Biologics
10-Jun-2024 Meril Announces Prestigious LANCET Publication for Landmark RCT of the MYVAL THV Series, Researched and Developed by INDIA Meril Life Sciences
10-Jun-2024 NEWFOUNDLAND DIAGNOSTICS APPOINTS DR HILARY JONES TO ADVISORY ROLE NEWFOUNDLAND DIAGNOSTICS
10-Jun-2024 Macomics Announces Appointment of Simon Dew as New Chief Business Officer Macomics
10-Jun-2024 Cumulus Oncology Appoints Catherine Lewis La Torre to its Board of Directors Cumulus Oncology
10-Jun-2024 Commit Biologics to present data on its Bispecific Complement Engaging (BiCE™) platform at the 16th International Conference on Complement Therapeutics Commit Biologics
07-Jun-2024 New US headquarters opened by mass photometry pioneers Refeyn Refeyn
06-Jun-2024 Beckman Coulter Life Sciences Releases Innovative Assay to Quantify Antibody Aggregation Beckman Coulter Life Sciences
06-Jun-2024 Clinigen acquires boutique market access consultancy Ascenian to accelerate access to lifesaving treatments Clinigen
06-Jun-2024 KITE RECEIVES EUROPEAN MEDICINES AGENCY APPROVAL OF SAFETY MONITORING VARIATION FOR CAR T-CELL THERAPY PORTFOLIO Gilead Sciences
06-Jun-2024 CYCLE PHARMACEUTICALS ANNOUNCES ALL-CASH PROPOSAL TO ACQUIRE VANDA PHARMACEUTICALS FOR $8.00 PER SHARE Cycle Pharmaceuticals
05-Jun-2024 OrganaBio expands California CPC Services hub for sample processing and cryopreservation capabilities to support Big Pharma clinical trials OrganaBio
05-Jun-2024 Celerion Honored With Prestigious CRO Leadership Award for Ninth Consecutive Year Celerion
05-Jun-2024 Quell Therapeutics Advances QEL-001, its Multi-modular Engineered CAR-Treg Cell Therapy, into Efficacy Cohort of LIBERATE Phase 1/2 Trial in Liver Transplant Patients Quell Therapeutics
05-Jun-2024 OncoZenge participates in MASCC cancer care conference June 27-29 OncoZenge